Prevent cuts to NIH biomedical research that would raise health care costs, delay treatment breakthroughs, and undermine chronic disease cures.

An amendment that would direct the Senate to prevent cuts to the National Institutes of Health’s biomedical research that would raise health care costs, delay treatment breakthroughs, and undermine efforts to cure chronic disease.

Alsobrooks filed an amendment to prevent cuts to NIH biomedical research.

Senator Alsobrooks Forces Vote Capping Child Care Costs at 7% of Income
primary · speech · model gpt-5.5

Alsobrooks urged HHS to restore NIH operations to prevent further research disruptions.

Early in her Senate term, Alsobrooks joined an official letter demanding restoration of NIH study sections, advisory committees, communications, travel, and staffing functions after Trump administration restrictions disrupted the grant process.

partial same_term A for effort

Van Hollen, Alsobrooks, Raskin Sound Alarm on NIH Disruptions, Urge Immediate Restoration of Operations
secondary · model gpt-5.5 · confidence 90%

The letter asked NIH to rescind guidance causing abrupt and deeply damaging research cuts.

Alsobrooks and Maryland colleagues directly opposed NIH indirect-cost guidance that would cut reimbursements for Maryland research institutions and clinical trials, citing risks to cures, patients, jobs, and biomedical research capacity.

partial same_term A for effort

February 20, 2025 NIH Letter to HHS and NIH
secondary · model gpt-5.5 · confidence 93%

The resolution opposed NIH interruption, delay, or funding disruption and defended NIH workforce capacity.

Congress.gov records S.Res.93 as an official Senate resolution cosponsored by Alsobrooks supporting uninterrupted NIH operations and funding. It is concrete legislative action, but a resolution alone did not enact funding protection.

partial same_term A for effort

S.Res.93 - NIH Operations and Workforce Resolution
secondary · model gpt-5.5 · confidence 88%

NIH reported FY2025 biomedical research investment grew and its total FY2025 appropriation was $48.5 billion.

Official NIH data show that, despite attempted administrative disruptions, overall NIH FY2025 biomedical research grant investment and research project grant funding increased rather than being cut.

delivered same_term

Fiscal Year 2025 By the Numbers: Extramural Grant Investments in Research
secondary · model gpt-5.5 · confidence 90%

The bill provided $48.7 billion for NIH biomedical investments in research.

The FY2026 Labor-HHS appropriations package approved by Congress funded NIH biomedical research at $48.7 billion, including targeted funding for cancer, Alzheimer’s, diabetes, ALS, rare disease, and related research, preventing a broad NIH cut in enacted appropriations.

delivered same_term

Congress Approves FY 2026 Labor, HHS, Education Appropriations Bill
secondary · model gpt-5.5 · confidence 91%

On H.R.7148 passage, the bill passed 71-29; Alsobrooks voted Nay.

Although the final FY2026 appropriations bill preserved NIH funding, Alsobrooks voted against final Senate passage. This limits personal fulfillment credit to partial, even though she took other concrete actions opposing NIH cuts.

partial same_term

U.S. Senate Roll Call Vote 20, 119th Congress, 2nd Session
secondary · model gpt-5.5 · confidence 94%